A Comprehensive Review of the Underlying Mechanisms of Resistance and Therapeutic Options for DTR-PA in Bloodstream Infection and Pneumonia: A Clinical Vignette-Based Approach. [PDF]
Maraolo AE +11 more
europepmc +1 more source
In Vitro Activity of Aztreonam-Avibactam, Cefiderocol, and Conventional Antimicrobials Against Metallo-β-Lactamase-Producing Gram-Negative Urinary Isolates: A Systematic Review and Local Single-Center Retrospective Evaluation in a Tertiary Care Hospital (2016-2025) and Evaluation of Novel Agents (2021-2025). [PDF]
Requena-Fernández L +4 more
europepmc +1 more source
Inoculum-dependent activity of contemporary β-lactam agents against carbapenemase- producing Enterobacterales. [PDF]
Sahu TK, Gadkari P, Rathored J.
europepmc +1 more source
Molecular characterization of carbapenemase-producing Enterobacterales from Peshawar City, Khyber Pakhtunkhwa, Pakistan. [PDF]
Mancini S +8 more
europepmc +1 more source
Impact of medium composition on cefiderocol susceptibility testing: comparison of CLSI/EUCAST-compliant and commercial broth microdilution methods. [PDF]
Turowski P +2 more
europepmc +1 more source
Evaluation of cefiderocol trailing and other unclear susceptibility testing endpoints for <i>Acinetobacter</i> spp. [PDF]
Castanheira M +4 more
europepmc +1 more source
A siderophore-independent lanthipeptide carrier enables Trojan-horse delivery of antibacterial cargoes into Gram-negative bacteria. [PDF]
Wang B +11 more
europepmc +1 more source
A case of prolonged cefiderocol therapy during continuous hemodiafiltration in a patient with an implanted left ventricular assist device. [PDF]
Kimura H +7 more
europepmc +1 more source
Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms-a narrative review for an enablement strategy. [PDF]
Eckmann C +16 more
europepmc +1 more source
<i>In vitro</i> activities of zosurabalpin and comparator antimicrobials against clinical isolates of carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]
Lin Y-T +6 more
europepmc +1 more source

